In this report, the United States Trastuzumab market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Trastuzumab in these regions, from 2012 to 2022 (forecast).
United States Trastuzumab market competition by top manufacturers/players, with Trastuzumab sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Genentech Inc
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Human Source
Animal Source
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Trastuzumab for each application, including
Hospital
Medical Center
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Trastuzumab Market Report 2017
1 Trastuzumab Overview
1.1 Product Overview and Scope of Trastuzumab
1.2 Classification of Trastuzumab by Product Category
1.2.1 United States Trastuzumab Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Trastuzumab Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Human Source
1.2.4 Animal Source
1.3 United States Trastuzumab Market by Application/End Users
1.3.1 United States Trastuzumab Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Medical Center
1.4 United States Trastuzumab Market by Region
1.4.1 United States Trastuzumab Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Trastuzumab Status and Prospect (2012-2022)
1.4.3 Southwest Trastuzumab Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Trastuzumab Status and Prospect (2012-2022)
1.4.5 New England Trastuzumab Status and Prospect (2012-2022)
1.4.6 The South Trastuzumab Status and Prospect (2012-2022)
1.4.7 The Midwest Trastuzumab Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Trastuzumab (2012-2022)
1.5.1 United States Trastuzumab Sales and Growth Rate (2012-2022)
1.5.2 United States Trastuzumab Revenue and Growth Rate (2012-2022)
2 United States Trastuzumab Market Competition by Players/Suppliers
2.1 United States Trastuzumab Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Trastuzumab Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Trastuzumab Average Price by Players/Suppliers (2012-2017)
2.4 United States Trastuzumab Market Competitive Situation and Trends
2.4.1 United States Trastuzumab Market Concentration Rate
2.4.2 United States Trastuzumab Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Trastuzumab Manufacturing Base Distribution, Sales Area, Product Type
3 United States Trastuzumab Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Trastuzumab Sales and Market Share by Region (2012-2017)
3.2 United States Trastuzumab Revenue and Market Share by Region (2012-2017)
3.3 United States Trastuzumab Price by Region (2012-2017)
4 United States Trastuzumab Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Trastuzumab Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Trastuzumab Revenue and Market Share by Type (2012-2017)
4.3 United States Trastuzumab Price by Type (2012-2017)
4.4 United States Trastuzumab Sales Growth Rate by Type (2012-2017)
5 United States Trastuzumab Sales (Volume) by Application (2012-2017)
5.1 United States Trastuzumab Sales and Market Share by Application (2012-2017)
5.2 United States Trastuzumab Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Trastuzumab Players/Suppliers Profiles and Sales Data
6.1 Genentech Inc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Trastuzumab Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Genentech Inc Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis AG
6.2.2 Trastuzumab Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis AG Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Pfizer
6.3.2 Trastuzumab Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Pfizer Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Abnova Corporation
6.4.2 Trastuzumab Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Abnova Corporation Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 InvivoGen
6.5.2 Trastuzumab Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 InvivoGen Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Celltrion
6.6.2 Trastuzumab Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Celltrion Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Biocon Limited
6.7.2 Trastuzumab Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Biocon Limited Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Bio-Techne
6.8.2 Trastuzumab Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bio-Techne Trastuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
7 Trastuzumab Manufacturing Cost Analysis
7.1 Trastuzumab Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Trastuzumab
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Trastuzumab Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Trastuzumab Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Trastuzumab Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Trastuzumab Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Trastuzumab Sales Volume Forecast by Type (2017-2022)
11.3 United States Trastuzumab Sales Volume Forecast by Application (2017-2022)
11.4 United States Trastuzumab Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Trastuzumab
Figure United States Trastuzumab Market Size (K Pcs) by Type (2012-2022)
Figure United States Trastuzumab Sales Volume Market Share by Type (Product Category) in 2016
Figure Human Source Product Picture
Figure Animal Source Product Picture
Figure United States Trastuzumab Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Trastuzumab by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure United States Trastuzumab Market Size (Million USD) by Region (2012-2022)
Figure The West Trastuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Trastuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Trastuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Trastuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Trastuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Trastuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Trastuzumab Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Trastuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Trastuzumab Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Trastuzumab Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Trastuzumab Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Trastuzumab Sales Share by Players/Suppliers
Figure 2017 United States Trastuzumab Sales Share by Players/Suppliers
Figure United States Trastuzumab Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Trastuzumab Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Trastuzumab Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Trastuzumab Revenue Share by Players/Suppliers
Figure 2017 United States Trastuzumab Revenue Share by Players/Suppliers
Table United States Market Trastuzumab Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Trastuzumab Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Trastuzumab Market Share of Top 3 Players/Suppliers
Figure United States Trastuzumab Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Trastuzumab Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Trastuzumab Product Category
Table United States Trastuzumab Sales (K Pcs) by Region (2012-2017)
Table United States Trastuzumab Sales Share by Region (2012-2017)
Figure United States Trastuzumab Sales Share by Region (2012-2017)
Figure United States Trastuzumab Sales Market Share by Region in 2016
Table United States Trastuzumab Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Trastuzumab Revenue Share by Region (2012-2017)
Figure United States Trastuzumab Revenue Market Share by Region (2012-2017)
Figure United States Trastuzumab Revenue Market Share by Region in 2016
Table United States Trastuzumab Price (USD/Pcs) by Region (2012-2017)
Table United States Trastuzumab Sales (K Pcs) by Type (2012-2017)
Table United States Trastuzumab Sales Share by Type (2012-2017)
Figure United States Trastuzumab Sales Share by Type (2012-2017)
Figure United States Trastuzumab Sales Market Share by Type in 2016
Table United States Trastuzumab Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Trastuzumab Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Trastuzumab by Type (2012-2017)
Figure Revenue Market Share of Trastuzumab by Type in 2016
Table United States Trastuzumab Price (USD/Pcs) by Types (2012-2017)
Figure United States Trastuzumab Sales Growth Rate by Type (2012-2017)
Table United States Trastuzumab Sales (K Pcs) by Application (2012-2017)
Table United States Trastuzumab Sales Market Share by Application (2012-2017)
Figure United States Trastuzumab Sales Market Share by Application (2012-2017)
Figure United States Trastuzumab Sales Market Share by Application in 2016
Table United States Trastuzumab Sales Growth Rate by Application (2012-2017)
Figure United States Trastuzumab Sales Growth Rate by Application (2012-2017)
Table Genentech Inc Basic Information List
Table Genentech Inc Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genentech Inc Trastuzumab Sales Growth Rate (2012-2017)
Figure Genentech Inc Trastuzumab Sales Market Share in United States (2012-2017)
Figure Genentech Inc Trastuzumab Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Trastuzumab Sales Growth Rate (2012-2017)
Figure Novartis AG Trastuzumab Sales Market Share in United States (2012-2017)
Figure Novartis AG Trastuzumab Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Trastuzumab Sales Growth Rate (2012-2017)
Figure Pfizer Trastuzumab Sales Market Share in United States (2012-2017)
Figure Pfizer Trastuzumab Revenue Market Share in United States (2012-2017)
Table Abnova Corporation Basic Information List
Table Abnova Corporation Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abnova Corporation Trastuzumab Sales Growth Rate (2012-2017)
Figure Abnova Corporation Trastuzumab Sales Market Share in United States (2012-2017)
Figure Abnova Corporation Trastuzumab Revenue Market Share in United States (2012-2017)
Table InvivoGen Basic Information List
Table InvivoGen Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure InvivoGen Trastuzumab Sales Growth Rate (2012-2017)
Figure InvivoGen Trastuzumab Sales Market Share in United States (2012-2017)
Figure InvivoGen Trastuzumab Revenue Market Share in United States (2012-2017)
Table Celltrion Basic Information List
Table Celltrion Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celltrion Trastuzumab Sales Growth Rate (2012-2017)
Figure Celltrion Trastuzumab Sales Market Share in United States (2012-2017)
Figure Celltrion Trastuzumab Revenue Market Share in United States (2012-2017)
Table Biocon Limited Basic Information List
Table Biocon Limited Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biocon Limited Trastuzumab Sales Growth Rate (2012-2017)
Figure Biocon Limited Trastuzumab Sales Market Share in United States (2012-2017)
Figure Biocon Limited Trastuzumab Revenue Market Share in United States (2012-2017)
Table Bio-Techne Basic Information List
Table Bio-Techne Trastuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bio-Techne Trastuzumab Sales Growth Rate (2012-2017)
Figure Bio-Techne Trastuzumab Sales Market Share in United States (2012-2017)
Figure Bio-Techne Trastuzumab Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Trastuzumab
Figure Manufacturing Process Analysis of Trastuzumab
Figure Trastuzumab Industrial Chain Analysis
Table Raw Materials Sources of Trastuzumab Major Players/Suppliers in 2016
Table Major Buyers of Trastuzumab
Table Distributors/Traders List
Figure United States Trastuzumab Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Trastuzumab Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Trastuzumab Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Trastuzumab Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Trastuzumab Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Trastuzumab Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Trastuzumab Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Trastuzumab Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Trastuzumab Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Trastuzumab Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Trastuzumab Sales Volume Share Forecast by Region (2017-2022)
Figure United States Trastuzumab Sales Volume Share Forecast by Region (2017-2022)
Figure United States Trastuzumab Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
